Acupuncture Treatment for Improving Alzheimer's Dementia
Primary Purpose
Cognitive Deficits, Alzheimer Disease
Status
Withdrawn
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Acupunture
Sponsored by
About this trial
This is an interventional treatment trial for Cognitive Deficits focused on measuring Acupunture
Eligibility Criteria
Inclusion Criteria:
- Mild to moderate AD
Exclusion Criteria:
- Severe AD
Sites / Locations
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Acupuncture
Arm Description
Acupuncture 12 sessions over 6 week to be given to pateints
Outcomes
Primary Outcome Measures
Improvement on Montreal Cognitive Assessment test of 5 points or more than baseline( total score is out of 30 points)
Subject will complete 3 MOCA assessment prior to study over 1 week time. Best score of three is used.
After study is complete subject will also undergo 3 MOCA assessment over 1 week immediately after study. Again best score is used.
Secondary Outcome Measures
Improvement of Montreal Cognitive Assessment test by category than raw total score
performance on various subcategory will also be reviewed to see if one category improves over other category. (Example: Visual-spacial parameters improves over language)
Full Information
NCT ID
NCT04064021
First Posted
April 28, 2015
Last Updated
October 7, 2022
Sponsor
N & S Neurology Center, A Medical Group, Inc
1. Study Identification
Unique Protocol Identification Number
NCT04064021
Brief Title
Acupuncture Treatment for Improving Alzheimer's Dementia
Official Title
Clinical Trial to Measure Efficacy of Acupuncture Treatment for Alzheimer's Dementia as Measured by MOCA(Montreal Cognitive Assessment)
Study Type
Interventional
2. Study Status
Record Verification Date
October 2022
Overall Recruitment Status
Withdrawn
Why Stopped
due to covid19 pandemic
Study Start Date
January 1, 2025 (Anticipated)
Primary Completion Date
December 31, 2026 (Anticipated)
Study Completion Date
March 31, 2027 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
N & S Neurology Center, A Medical Group, Inc
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Evaluate cognitive improvement pre amd post acupuncture treatment in patients with probable alzheimer's dementia as measured by MOCA score and also per form A( measure of patient's personal information). Also caregiver input.
Detailed Description
Patient's with diagnosis of probable mild to moderate AD will be enrolled in this study. Patient will undergo neurological examination including MOCA. Examiner will also fill out Form A at the time of initial evaluation.
Patient will then undergo series of acupuncture treatments 2 per week for 6 weeks(12 acupuncture treatment). At end of this intervention patients will be reassessed using same testing(MOCA and form A) Data collected will be assessed via statistical analysis to see if there is any statistically significant improvement.
Acupuncture points used in this trial will stay the same for all subjects and throughout the course. The points will be Si Shen Chong, ST36, 37, LV 2,3,6, GB 34, 39, Xia San Huang, LI 11, LI 4.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cognitive Deficits, Alzheimer Disease
Keywords
Acupunture
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
0 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Acupuncture
Arm Type
Experimental
Arm Description
Acupuncture 12 sessions over 6 week to be given to pateints
Intervention Type
Procedure
Intervention Name(s)
Acupunture
Intervention Description
Patient will receive 12 acupuncture treatments over 6 weeks (2x per week)
Primary Outcome Measure Information:
Title
Improvement on Montreal Cognitive Assessment test of 5 points or more than baseline( total score is out of 30 points)
Description
Subject will complete 3 MOCA assessment prior to study over 1 week time. Best score of three is used.
After study is complete subject will also undergo 3 MOCA assessment over 1 week immediately after study. Again best score is used.
Time Frame
12 weeks
Secondary Outcome Measure Information:
Title
Improvement of Montreal Cognitive Assessment test by category than raw total score
Description
performance on various subcategory will also be reviewed to see if one category improves over other category. (Example: Visual-spacial parameters improves over language)
Time Frame
12 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
60 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Mild to moderate AD
Exclusion Criteria:
Severe AD
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
SANJAY CHAUHAN, M.D.
Organizational Affiliation
N & S Neurology Center, A Medical Group, Inc
Official's Role
Principal Investigator
12. IPD Sharing Statement
Learn more about this trial
Acupuncture Treatment for Improving Alzheimer's Dementia
We'll reach out to this number within 24 hrs